mTOR is regulated by phosphatidylinositol 3-kinase/Akt pathway to participate in proliferation, angiogenesis and metastasis of CRC (40) and inhibition of mTOR could emerge as a potential strategy for cancer intervention of CRC (41–43). Here, AKT1 is linked to cancer.